Application of the GBM-X data platform to estimate treatment effects of the experimental therapies of the randomized phase 2 individualized screening trial of innovative glioblastoma therapies Meeting Abstract
| Authors: | Rahman, R.; Trippa, L.; Fell, G.; Lee, E.; Arrillaga-Romany, I.; Touat, M.; Drappatz, J.; Welch, M.; Galanis, E.; Ahluwalia, M.; Colman, H.; Nabors, B.; Hepel, J.; Elinzano, H.; Schiff, D.; Chukwueke, U.; Beroukhim, R.; Nayak, L.; McFaline-Figueroa, J. R.; Batchelor, T.; Rinne, M.; Kaley, T.; Lu-Emerson, C.; Mellinghoff, I.; Bi, W. L.; Arnaout, O.; Peruzzi, P. P.; Haas-Kogan, D.; Tanguturi, S.; Cagney, D.; Aizer, A.; Doherty, L.; Santagata, S.; Meredith, D.; Chiocca, E. A.; Reardon, D.; Alexander, B.; Ligon, K.; Wen, P. |
| Abstract Title: | Application of the GBM-X data platform to estimate treatment effects of the experimental therapies of the randomized phase 2 individualized screening trial of innovative glioblastoma therapies |
| Meeting Title: | 28th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 25 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2023 Nov 15-19 |
| Meeting Location: | Vancouver, Canada |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | v76 |
| End Page: | v77 |
| Language: | English |
| ACCESSION: | WOS:001115245400300 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noad179.0299 |
| Notes: | Meeting Abstract: CTNI-17 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
269Mellinghoff -
154Kaley
Related MSK Work